Prostate Cancer
November 1, 2015
This management guide covers the treatment, diagnosis, and staging of prostate cancer.
Andrew J. Armstrong, MD, MSc
Treatment of Castration-Resistant Prostate Cancer: Current Options and Novel Therapies
April 27, 2012
Two experts discuss newly available and upcoming treatment options, such as abiraterone and MDV3100, for patients with castration-resistant prostate cancer.
What to Order From the Prostate Cancer Treatment Menu?
January 17, 2012
These are, indeed, exciting times for patients with metastatic prostate cancer and the clinicians who care for them.
ASCO 2010: Selected Sessions in Renal Cell Carcinoma
July 2, 2010
In 2010, we have the clinical opportunity to choose among several “targeted” agents when treating patients with metastatic renal cell carcinoma (RCC).
New Generation of Targeted Therapies Show Promise in RCC
June 8, 2010
In this exclusive ASCO podcast, Andrew J. Armstrong, MD, ScM, Assistant Professor of Medicine and Surgery Duke Comprehensive Cancer Center, Departments of Medicine and Surgery, Divisions of Medical Oncology and Urology, addressed the vexing clinical issue of chemotherapy’s limited effectiveness in advanced renal cell carcinoma.
